 
		
					AI and omics unlock personalized drugs and RNA therapies for heart disease
AI, omics, and systems biology can now help scientists design targeted drugs for cardiovascular disease pathways once thought “untreatable.”This article was originally published on MedicalXpress.com

 
		 
		 
		 
		 
		 
		 
		 
		